Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Journal article

Palace J. et al, (2019), Brain, 142, 1310 - 1323

Area postrema syndrome

Journal article

Shosha E. et al, (2018), Neurology, 91, e1642 - e1651

Corrigendum

Journal article

(2018), Brain, 141, e31 - e31

Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody

Journal article

Hacohen Y. et al, (2018), Multiple Sclerosis Journal, 24, 679 - 684

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Journal article

Jurynczyk M. et al, (2017), Brain, 140, 3128 - 3138

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Journal article

Jurynczyk M. et al, (2017), Brain, 140, 3128 - 3138

Disease course and disability outcomes in MOG-antibody disease in the UK

Conference paper

Jurynczyk M. et al, (2017), MULTIPLE SCLEROSIS JOURNAL, 23, 82 - 82

Smoking on disability accumulation in neuromyelitis optica and multiple sclerosis

Conference paper

Messina S. et al, (2017), MULTIPLE SCLEROSIS JOURNAL, 23, 214 - 214

Risk factors in multiple sclerosis: a population-based case–control study in Sicily. Background and methods

Journal article

Nicoletti A. et al, (2016), Neurological Sciences, 37, 1931 - 1937

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Journal article

Patti F. et al, (2016), Journal of Neurology, Neurosurgery & Psychiatry, 87, 944 - 951

Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity

Journal article

Bove R. et al, (2016), Multiple Sclerosis and Related Disorders, 8, 136 - 140

A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis

Journal article

D’Amico E. et al, (2015), Expert Opinion on Drug Safety, 14, 1157 - 1168

Restless legs syndrome and multiple sclerosis: a population based case−control study in Catania, Sicily

Journal article

Bruno E. et al, (2015), European Journal of Neurology, 22, 1018 - 1021

Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily

Journal article

Patti F. et al, (2015), Journal of Neurology, 262, 923 - 930

Lesion Load May Predict Long-Term Cognitive Dysfunction in Multiple Sclerosis Patients

Journal article

Patti F. et al, (2015), PLOS ONE, 10, e0120754 - e0120754

Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide

Journal article

Patti F. et al, (2014), Acta Neurologica Scandinavica, 130, e41 - e44

Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI

Journal article

Messina S. and Patti F., (2014), Multiple Sclerosis International, 2014, 1 - 9

Multiple Sclerosis in the Mount Etna Region: Possible Role of Volcanogenic Trace Elements

Journal article

Nicoletti A. et al, (2013), PLoS ONE, 8, e74259 - e74259

Load More